Roquefort Therapeutics PLC is engaged in pursuing opportunities to acquire medical biotechnology businesses... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| STVYX | 18.23 | 0.14 | +0.77% |
| SEI Tax-Managed Mgd Volatility Y (SIMT) | |||
| DRGVX | 48.78 | 0.32 | +0.66% |
| BNY Mellon Dynamic Value Fund I | |||
| DIAMX | 28.65 | 0.11 | +0.39% |
| Diamond Hill Long-Short Inv | |||
| LSHAX | 31.23 | 0.11 | +0.35% |
| Kinetics Spin-Off and Corp Rest Adv A | |||
| EGLNX | 10.68 | -0.01 | -0.09% |
| Eagle Energy Infrastructure N | |||
A.I.dvisor indicates that over the last year, ROQAF has been closely correlated with LYRA. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if ROQAF jumps, then LYRA could also see price increases.
| Ticker / NAME | Correlation To ROQAF | 1D Price Change % | ||
|---|---|---|---|---|
| ROQAF | 100% | N/A | ||
| LYRA - ROQAF | 85% Closely correlated | -3.33% | ||
| EYPT - ROQAF | 37% Loosely correlated | +0.62% | ||
| RIGL - ROQAF | 22% Poorly correlated | +1.50% | ||
| RYTM - ROQAF | 21% Poorly correlated | -1.72% | ||
| OKYO - ROQAF | 3% Poorly correlated | -4.47% | ||
More | ||||